ISPC iSpecimen Inc. Stock Quote

ISPC [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-1.26	Insider Own	25.50%	Shs Outstand	6.49M	Perf Week	33.64%
Market Cap	49.32M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.16M	Perf Month	24.61%
Income	-8.20M	PEG	-	EPS next Q	-	Inst Own	16.30%	Short Float	0.37%	Perf Quarter	25.92%
Sales	10.80M	P/S	4.57	EPS this Y	1.60%	Inst Trans	0.45%	Short Ratio	0.21	Perf Half Y	-
Book/sh	1.64	P/B	4.38	EPS next Y	-	ROA	-87.00%	Target Price	-	Perf Year	-
Cash/sh	1.92	P/C	3.74	EPS next 5Y	-	ROE	44.60%	52W Range	5.10 - 10.00	Perf YTD	0.56%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	16.60%	52W High	-25.00%	Beta	-
Dividend %	-	Quick Ratio	-	Sales past 5Y	-	Gross Margin	48.60%	52W Low	47.06%	ATR	0.40
Employees	46	Current Ratio	2.90	Sales Q/Q	93.30%	Oper. Margin	-57.90%	RSI (14)	75.64	Volatility	10.68% 5.88%
Optionable	No	Debt/Eq	0.28	EPS Q/Q	-700.50%	Profit Margin	-75.70%	Rel Volume	1.73	Prev Close	7.19
Shortable	Yes	LT Debt/Eq	0.28	Earnings	-	Payout	-	Avg Volume	89.56K	Price	7.50
Recom	-	SMA20	27.36%	SMA50	24.09%	SMA200	21.55%	Volume	154,603	Change	4.31%

Oct-07-21 08:00AM	iSpecimen Expands Global Biospecimen Supplier Network and Access to Human Biospecimens Needed to Help Accelerate Development of Liquid Biopsies PR Newswire
Sep-14-21 08:00AM	iSpecimen Announces Inclusion in Russell Microcap® Index PR Newswire
Sep-01-21 08:30AM	iSpecimen to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13-15, 2021 PR Newswire -5.15%
Aug-18-21 07:00AM	iSpecimen Expands Human Biospecimen Offerings for Cancer Researchers PR Newswire
Aug-12-21 09:00AM	iSpecimen Inc. Interview to Air on the RedChip Money Report® on Bloomberg TV PR Newswire
Aug-10-21 07:00AM	iSpecimen Reports Second Quarter 2021 Financial Results PR Newswire
Jul-29-21 07:50AM	iSpecimen Launches Enhanced Custom Collection Service PR Newswire +7.93%
Jul-27-21 07:00AM	iSpecimen to Report Second Quarter 2021 Results on August 10, 2021 PR Newswire
Jul-01-21 11:18AM	iSpecimen Announces Closing of Over-Allotment Option in Connection with its Initial Public Offering PR Newswire
Jun-21-21 02:20PM	iSpecimen Announces Closing of Initial Public Offering PR Newswire
Jun-16-21 07:05PM	iSpecimen Announces Pricing of Initial Public Offering PR Newswire

iSpecimen, Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables researchers to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience